Bill Steinkrauss, Chief Financial Officer. Bill has more than 18 years of financial and executive leadership experience. Bill is the founder of OWL CFO Consulting LLC, a consulting firm providing part-time CFO services to companies in the biotechnology industry. Prior to OWL CFO Consulting, he served as Chief Financial Officer and Chief Administrative Officer of Curis, Inc., a publicly traded biotechnology company. In his experience as CFO, Bill has led various financings that raised over $350 million of proceeds. He previously worked in the finance departments at Ovascience, Inc., and at Cubist Pharmaceuticals, Inc., through its acquisition by Merck in 2015. Prior to joining the biopharma industry, Bill worked within the capital markets advisory and assurance practices at PricewaterhouseCoopers, LLP. He holds a B.S. in accounting and finance and an M.S. in accounting from Boston College. Bill is a certified public accountant.